AGTC - Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2022 Results - Earnings Call Transcript

Applied Genetic Technologies Corporation (AGTC) Q2 2022 Earnings Conference Call February 14, 2022 8:00 AM ET Company Participants Sue Washer – Chief Executive Officer Susan Schneider – Chief Medical Officer Jon Lieber – Chief Financial Officer Conference Call Participants Joe Pantginis – H.C. Wainright Dae Gon Ha – Stifel Yanan Zhu – Wells Fargo Kristen Kluska – Cantor Fitzgerald Yun Zhong – BTIG Zegbeh Jallah – ROTH Capital Presentation Operator Good morning, and welcome to the AGTC Financial Results Conference Call for the Second Quarter of Fiscal year 2022. Today's call is being recorded. Before we get started, I would like to remind everyone that during this call, AGTC may make forward-looking statements, including statements about the company's financial results, financial guidance, its future business strategies and operations and its product development and regulatory progress, including statements about the timing and outcomes from data expected in its SKYLINE and VISTA

For further details see:

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2022 Results - Earnings Call Transcript